116 related articles for article (PubMed ID: 22831649)
21. Extremely low-dose ACTH step-up protocol for West syndrome: maximum therapeutic effect with minimal side effects.
Oguni H; Yanagaki S; Hayashi K; Imai K; Funatsuka M; Kishi T; Osawa M
Brain Dev; 2006 Jan; 28(1):8-13. PubMed ID: 15925463
[TBL] [Abstract][Full Text] [Related]
22. Decreased cerebrospinal fluid levels of beta-endorphin and ACTH in children with infantile spasms.
Nagamitsu S; Matsuishi T; Yamashita Y; Shimizu T; Iwanaga R; Murakami Y; Miyazaki M; Hashimoto T; Kato H
J Neural Transm (Vienna); 2001; 108(3):363-71. PubMed ID: 11341487
[TBL] [Abstract][Full Text] [Related]
23. [Changes of thyroid hormone levels during ACTH therapy in epileptic children].
Natori Y; Yamaguchi N; Koike S; Aoyama A; Kusakabe K; Demura R
Rinsho Byori; 1994 Jul; 42(7):753-8. PubMed ID: 8065044
[TBL] [Abstract][Full Text] [Related]
24. The concentrations of GABA, 5-HIAA and HVA in the cerebrospinal fluid of children with infantile spasms and the effects of ACTH treatment.
Airaksinen E; Tuomisto L; Riikonen R
Brain Dev; 1992 Nov; 14(6):386-90. PubMed ID: 1283505
[TBL] [Abstract][Full Text] [Related]
25. Infantile spasms: CSF proteins before and during treatment with ACTH.
Siemes H; Rating D; Hanefeld F
Dev Med Child Neurol; 1981 Jun; 23(3):384-6. PubMed ID: 6265306
[No Abstract] [Full Text] [Related]
26. Infantile spasm: the effect of corticotropin (ACTH) on the free amino acid profile in cerebrospinal fluid.
Tekgül H; Tütüncüoglu S; Coker M; Coker C
Brain Dev; 1999 Jan; 21(1):20-3. PubMed ID: 10082248
[TBL] [Abstract][Full Text] [Related]
27. Adrenocorticotropic hormone therapy for infantile spasms alters pyruvate metabolism in the central nervous system.
Miyazaki M; Hashimoto T; Yoneda Y; Saijio T; Mori K; Ito M; Kuroda Y
Brain Dev; 1998 Aug; 20(5):312-8. PubMed ID: 9761001
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor-1 is associated with cognitive outcome in infantile spasms.
Riikonen RS; Jääskeläinen J; Turpeinen U
Epilepsia; 2010 Jul; 51(7):1283-9. PubMed ID: 20163445
[TBL] [Abstract][Full Text] [Related]
29. [Infantile spasms and West syndrome].
Diaconu G; Grigore I
Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):40-5. PubMed ID: 15688754
[TBL] [Abstract][Full Text] [Related]
30. West syndrome associated with mosaic Down syndrome.
Kajimoto M; Ichiyama T; Akashi A; Suenaga N; Matsufuji H; Furukawa S
Brain Dev; 2007 Aug; 29(7):447-9. PubMed ID: 17307326
[TBL] [Abstract][Full Text] [Related]
31. A plausible explanation for superiority of adreno-cortico-trophic hormone (ACTH) over oral corticosteroids in management of infantile spasms (West syndrome).
Jaseja H
Med Hypotheses; 2006; 67(4):721-4. PubMed ID: 16781824
[TBL] [Abstract][Full Text] [Related]
32. Axonal and astrocyte injury markers in the cerebrospinal fluid of Kenyan children with severe malaria.
Medana IM; Idro R; Newton CR
J Neurol Sci; 2007 Jul; 258(1-2):93-8. PubMed ID: 17459417
[TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid interleukin-6 levels in patients with West syndrome.
Tekgul H; Polat M; Tosun A; Serdaroglu G; Kutukculer N; Gokben S
Brain Dev; 2006 Jan; 28(1):19-23. PubMed ID: 15967615
[TBL] [Abstract][Full Text] [Related]
34. Three-week combination treatment with ACTH + magnesium sulfate versus ACTH monotherapy for infantile spasms: a 24-week, randomized, open-label, follow-up study in China.
Zou LP; Wang X; Dong CH; Chen CH; Zhao W; Zhao RY
Clin Ther; 2010 Apr; 32(4):692-700. PubMed ID: 20435238
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic efficacy and adverse effects of adrenocorticotropic hormone therapy in west syndrome: differences in dosage of adrenocorticotropic hormone, onset of age, and cause.
Hamano S; Yamashita S; Tanaka M; Yoshinari S; Minamitani M; Eto Y
J Pediatr; 2006 Apr; 148(4):485-8. PubMed ID: 16647410
[TBL] [Abstract][Full Text] [Related]
36. Combination treatment of high-dose pyridoxal phosphate and low-dose ACTH in children with West syndrome and related disorders.
Seki T
Jpn J Psychiatry Neurol; 1990 Jun; 44(2):219-37. PubMed ID: 1701836
[TBL] [Abstract][Full Text] [Related]
37. Increase in beta-amyloid levels in cerebrospinal fluid of children with Down syndrome.
Englund H; Annerén G; Gustafsson J; Wester U; Wiltfang J; Lannfelt L; Blennow K; Höglund K
Dement Geriatr Cogn Disord; 2007; 24(5):369-74. PubMed ID: 17914261
[TBL] [Abstract][Full Text] [Related]
38. Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis.
Hein Née Maier K; Köhler A; Diem R; Sättler MB; Demmer I; Lange P; Bähr M; Otto M
Neurosci Lett; 2008 May; 436(1):72-6. PubMed ID: 18359164
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid GABA levels in children with infantile spasms.
Ito M; Mikawa H; Taniguchi T
Neurology; 1984 Feb; 34(2):235-8. PubMed ID: 6320056
[TBL] [Abstract][Full Text] [Related]
40. Increased cerebrospinal fluid cleaved tau protein (C-tau) levels suggest axonal damage in pediatric patients with brain tumors.
Cengiz P; Zemlan F; Eickhoff JC; Ellenbogen R; Zimmerman JJ
Childs Nerv Syst; 2015 Aug; 31(8):1313-9. PubMed ID: 25899850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
